A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds
|
|||||
|
       
  |
Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism. . . . → Read More: Small Antibody Shown to Block Covid-19 Infection 
An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain. . . . → Read More: Brain Signal Synchronization Device in Development 
An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways. . . . → Read More: Vaccine Blocks Covid-19 Infections in Animal Tests  One comment - (Comments are closed)  New products  biomedical, biotechnology, clinical trials, Covid-19, life sciences, nanotechnology, pharmaceuticals, preclinical 
An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease. . . . → Read More: Small Biz Grant Advances Neuro Protection Drugs Comments are closed Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, grant, life sciences, NIH, pharmaceuticals, preclinical, university
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases. . . . → Read More: Start-Up to Engineer T-Cells for Autoimmune Diseases 2 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, entrepreneurs, equity, genomics, investment, Israel, licensing, life sciences, manufacturing, pharmaceuticals, preclinical, university, venture capital 
Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks. . . . → Read More: Two Covid-19 Vaccines Show Preclinical Immune Responses One comment - (Comments are closed) New products biomedical, biotechnology, Covid-19, life sciences, pharmaceuticals, preclinical 
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines. . . . → Read More: Synthetic Protein Designed to Boost Covid-19 Vaccines 2 comments - (Comments are closed) New products biomedical, biotechnology, chemistry, Covid-19, engineering, genomics, licensing, life sciences, patent, pharmaceuticals, physical sciences, preclinical, university 
A brain-computer interface device is shown to record the highest volume of brain signals from lab animals and sheep, according to its developers. . . . → Read More: High-Capacity Brain Signal Reader Demonstrated Comments are closed New products biomedical, biotechnology, computer science, engineering, entrepreneurs, life sciences, medical device, preclinical, semiconductors 
A new company is underway creating engineered antibodies to neutralize a range of coronaviruses, not just those causing Covid-19 infections. . . . → Read More: Start-Up Developing Coronavirus Antibodies, Raises $50M Comments are closed Finance, New products biomedical, biotechnology, Covid-19, entrepreneurs, equity, investment, life sciences, pharmaceuticals, preclinical, university, venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||